利纳林通过调节PI3K/Akt/mTOR通路,自和肠道微生物群来缓解高脂肪饮食引起的NAFLD
Mengfan Lv1, Yaxin Zhai1, Hao Yu1
1State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China.
概括
林 (Lin) 通过增强自和调节肠道微生物群,有效地减少非酒精性脂肪性肝病 (NAFLD) 的脂质积累. 它针对PI3K/Akt/mTOR通路,为NAFLD提供了潜在的治疗策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 微生物学 微生物学
背景情况:
- 非酒精性脂肪肝疾病 (NAFLD) 涉及与自和炎症的复杂相互作用.
- 林 (Lin) 是一种黄类化合物,具有已知的抗炎和抗肝保护性.
- 在NAFLD中Linarin的治疗潜力仍然在很大程度上未被研究.
研究的目的:
- 为了研究林纳林对NAFLD的保护作用.
- 阐明林纳林在NAFLD治疗中的潜在药理机制.
- 评估Linarin对脂质代谢,炎症,自和肠道微生物群的影响.
主要方法:
- 在体外 (AML12细胞与油脂/棕酸) 和体内 (高脂肪饮食小鼠) 建立的NAFLD模型.
- 使用Oil Red O和H&E染色评估脂质积累.
- 测量了炎症和自标志物,并通过16S rRNA测序分析了肠道微生物群组成.
主要成果:
- 在体外和体外模型中,利纳林显著降低了脂质积累.
- 利纳林增强了自和抑制了炎症因子的释放.
- 利纳林干预调节了肠道微生物群,减少了Firmicutes/Bacteroidetes和增加了Akkermansia/Bifidobacterium.
结论:
- 利纳林通过PI3K/Akt/mTOR通路激活自细胞来缓解NAFLD.
- 利纳林减轻脂质积累和炎症,可能通过恢复肠道微生物群平衡.
- 利纳林作为治疗非酒精性脂肪肝疾病的治疗剂显示出前景.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
01:26Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K